Value through Innovation17 January 2013
Corporate Profile
  • Home
  • Search Result

Page content

jump to main navigation jump to meta navigation

Your search results.

  1. 16 January 2013 Oncology

    U.S. FDA Grants Priority Review to Boehringer Ingelheim’s Afatinib* NDA for EGFR Mutation-Positive Advanced NSCLC

    • Size: 18 kB
    • Last Update: 16.01.2013

  2. Recommend

    You can recommend this page to a friend or colleague by completing the form below. The recipient will receive an e-mail with your name, personal message (if desired) and a link to the present webpage.

    • Size: 5 kB
    • Last Update: 16.01.2013

  3. Boehringer Ingelheim - Our Future has a History

    • Size: 30 kB
    • Last Update: 15.01.2013

  4. Video about our History

    Today, Boehringer Ingelheim has more than 44,000 employees at 145 branches worldwide, and with research centres on four continents it can justifiably endorse its claim to be a research-driven company.

    • Size: 2 kB
    • Last Update: 15.01.2013

  5. Boehringer Ingelheim - Our Future has a History

    • Size: 31 kB
    • Last Update: 10.01.2013

  6. Teaser: Iconlist (Web 2.0)

    • Size: 1 kB
    • Last Update: 10.01.2013

  7. Pinterest

    • Size: 1 kB
    • Last Update: 10.01.2013

  8. Hungary

    Boehringer Ingelheim, headquarterd in Germany, is a global business speard around the world, manufacturing and marketing pharmaceuticals, biopharmaceuticals, pharma chemicals and animal health products.

    • Size: 3 kB
    • Last Update: 7.01.2013

  9. Hungary

    • Size: 1 kB
    • Last Update: 7.01.2013

  10. 07 January 2013 Diabetes worldwide

    Lilly and Boehringer Ingelheim formed their diabetes alliance in January 2011, centering on four pipeline compounds representing several of the largest and most promising product classes.

    • Size: 12 kB
    • Last Update: 7.01.2013
back to top